
RYSE Asset Management
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Getting to the Future First. Since 2015, RYSE is one of Europe’s leading firms for health, technology, and impact.
Investor Profile
RYSE Asset Management has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Non Equity Assistance, Series Unknown, Pre Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Portugal.
- Strong thematic focus on Health Care, Software, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Non Equity Assistance (50%)
- Series Unknown (29%)
- Pre Seed (14%)
- Series A (7%)
Country Focus
- United Kingdom (71%)
- United States (14%)
- Portugal (7%)
- Spain (7%)
Industry Focus
- Health Care
- Software
- Medical
- Apps
- Information Technology
- Artificial Intelligence (Ai)
- Health Diagnostics
- Mhealth
- Therapeutics
- Electronic Health Record (Ehr)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.